Medical devices, healthcare technology and the business of care
PMA approval · P840024

NUCLEUS MULTICHANNEL IMPLANTABLE HEARING PROSTHESI

Cochlear Americas · Decision date Oct 31, 1985

FDA DECISIONP840024

What did the FDA approve?

FDA records P840024 as an original PMA application. The recorded decision is approval, dated Oct 31, 1985.

An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.

Regulatory pathway
Original PMA
Clinical specialty
Ear, Nose, Throat
Decision date
Oct 31, 1985

FDA source record

Regulatory record facts

Identifier
P840024
Regulatory pathway
Premarket approval application
Product code
MCM
Decision code
APPR
Decision date
Oct 31, 1985
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, cochlear.

Product code
MCM
FDA device class
3

FDA decision timeline

  1. P840024 received

    Application receipt date recorded by FDA.

  2. P840024 · FDA decision

    APPR

  3. P840024/S099 · Related supplement

    Nucleus 22 Cochlear Implant System

Timeline entries are records held by MedtechLedger for P840024. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P840024

Product / regulatory recordCompanyPathwayDecision dateSource
Cochlear AmericasPMA supplementSep 28, 2026FDA

Explore the linked device profile

Other records with product code MCM

Product / regulatory recordCompanyPathwayDecision dateSource
Med-El Corp.PMA supplementOct 9, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Advanced BionicsPMA supplementSep 18, 2026FDA
Advanced BionicsPMA supplementSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cochlear Americas

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
10350 Park Meadows Dr., Lone Tree, CO, 80124

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records